Cardiovascolare
Study links nighttime artificial light to higher cardiovascular risk
Riportato dall'IA Immagine generata dall'IA Verificato
A preliminary analysis from Boston researchers ties greater exposure to artificial light at night to heightened stress activity in the brain, arterial inflammation, and a higher risk of major heart events. The work will be presented at the American Heart Association’s Scientific Sessions 2025 in New Orleans on November 7–10 and frames light pollution as a potentially modifiable environmental factor.
L'Anvisa brasiliana ha approvato lunedì 2 febbraio 2026 l'espansione delle indicazioni terapeutiche del semaglutide, principio attivo di Wegovy e Ozempic. Wegovy può ora essere usato per ridurre il rischio di infarti e ictus negli adulti con malattia cardiovascolare e sovrappeso, mentre Ozempic è indicato per il diabete di tipo 2 associato a malattia renale cronica. L'agenzia sta anche esaminando una richiesta per una versione orale di Wegovy.
Riportato dall'IA Verificato
A comprehensive review in Beverage Plant Research concludes that evidence from human studies most strongly supports an association between tea consumption—particularly green tea—and lower risks of cardiovascular disease, obesity, type 2 diabetes and some cancers, while calling evidence for brain and muscle benefits “promising” but less settled. The authors also caution that bottled and bubble tea products, which can include added sugar and other additives, may blunt tea’s potential advantages.